Irritable bowel syndrome historical perspective

Jump to navigation Jump to search

Irritable bowel syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Irritable bowel syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Monitoring

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Irritable bowel syndrome historical perspective On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Irritable bowel syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Irritable bowel syndrome historical perspective

CDC on Irritable bowel syndrome historical perspective

Irritable bowel syndrome historical perspective in the news

Blogs on Irritable bowel syndrome historical perspective

Directions to Hospitals Treating Irritable bowel syndrome

Risk calculators and risk factors for Irritable bowel syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Overview

Irritable Bowel syndrome (IBS) was first mentioned in the Rocky Mountain Medical Journal in 1950. IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. Apley and Nash conducted a famous study on 1000 children in Bristol, United Kingdom and were the first to describe recurrent abdominal pain (RAP) as the predominant feature of IBS. In 1978, the first diagnostic criteria i.e. the Manning criteria was described. It did not specify any required duration for the symptoms of IBS. The subsequent criteria saw a reduction in the required duration of symptoms to facilitate early diagnosis and treatment. In Rome in 1995, an international group of gastroenterologists defined the diagnostic criteria for IBS and this was published in 1999 under the title of the Rome II criteria. This criteria underwent modification and was described as the Rome III criteria. Since June 2016, the criteria being followed is the Rome IV criteria.

Historical Perspective

Discovery

  • In 1950, the concept of irritable bowel syndrome (IBS) was mentioned for the first time without the recognition of any particular etiology, in the Rocky Mountain Medical Journal.
  •  IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. [1]
  • In 1958, Apley and Nash conducted a study on 1000 children in Bristol, United Kingdom and were the first to describe Recurrent Abdominal Pain (RAP), as the predominant feature of IBS.
  • Recurrent abdominal pain was defined as pain in the abdomen occurring over a duration of at least 3 months, with the severity enough to cause significant impairment of function.[2][3]

Landmark Events

Famous Cases

  • The following are a few famous cases of IBS:
    • Adolf Hitler
    • John F Kennedy
    • Kurt Cobain

References

  1. BROWN PW (1950). "The irritable bowel syndrome". Rocky Mt Med J. 47 (5): 343–6. PMID 15418074.
  2. APLEY J, NAISH N (1958). "Recurrent abdominal pains: a field survey of 1,000 school children". Arch. Dis. Child. 33 (168): 165–70. PMC 2012205. PMID 13534750.
  3. El-Matary W, Spray C, Sandhu B (2004). "Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children". Eur. J. Pediatr. 163 (10): 584–8. doi:10.1007/s00431-004-1503-0. PMID 15290263.
  4. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS (2006). "Childhood functional gastrointestinal disorders: child/adolescent". Gastroenterology. 130 (5): 1527–37. doi:10.1053/j.gastro.2005.08.063. PMID 16678566.
  5. Lacy BE, Patel NK (2017). "Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome". J Clin Med. 6 (11). doi:10.3390/jcm6110099. PMID 29072609.
  6. Iwańczak B, Iwańczak F (2017). "[Functional gastrointestinal disorders in children and adolescents. The Rome IV criteria]". Pol. Merkur. Lekarski (in Polish). 43 (254): 75–82. PMID 28875974.
  7. Ghoshal UC (2017). "Chronic constipation in Rome IV era: The Indian perspective". Indian J Gastroenterol. 36 (3): 163–173. doi:10.1007/s12664-017-0757-1. PMID 28643273.
  8. Ghoshal UC (2017). "Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros". J Neurogastroenterol Motil. 23 (3): 334–340. doi:10.5056/jnm17020. PMC 5503282. PMID 28672432.
  9. Saps M, van Tilburg MA, Lavigne JV, Miranda A, Benninga MA, Taminiau JA, Di Lorenzo C (2016). "Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials". Neurogastroenterol. Motil. 28 (11): 1619–1631. doi:10.1111/nmo.12896. PMID 27477090.
  10. Dang J, Ardila-Hani A, Amichai MM, Chua K, Pimentel M (2012). "Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III". Neurogastroenterol. Motil. 24 (9): 853–e397. doi:10.1111/j.1365-2982.2012.01943.x. PMID 22632582.
  11. Olden KW (2003). "The challenge of diagnosing irritable bowel syndrome". Rev Gastroenterol Disord. 3 Suppl 3: S3–11. PMID 14502111.

Template:WH Template:WS